The Centralized List annual renewal application and fee must be submitted to DOJ by January 31st of each year regardless of the date of initial placement on the Centralized List. The Centralized List portion of the annual fee is $20.00 per licensee at each dealership.
Hydrocodone Bitartrate, USP 7.5 mg. Ibuprofen, USP 200 mg. VICOPROFEN (hydrocodone and ibuprofen) is supplied in a fixed combination tablet form for oral administration. VICOPROFEN (hydrocodone and ibuprofen) combines the opioid analgesic agent, hydrocodone bitartrate, with the nonsteroidal anti-inflammatory (NSAID) agent, ibuprofen.
It is a brand name for hydromorphone, a Schedule II controlled substance in the U.S. This puts the drug in the same schedule class as morphine, OxyContin , Fentanyl and methadone. The U.S. Drug Enforcement Agency classifies drugs based on their potential to be habit-forming and to cause misuse and abuse.